This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The first pilot study from India analyzing Covaxin-Covishield mixed doses
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Flattish volume growth and subdued new launches were key factors for last month
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition
2022 is going to be the year of opportunities and innovations from the medical industry in India
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests
Subscribe To Our Newsletter & Stay Updated
